A61L2/00	7	Disinfection or sterilisation of materials or objects, in general; Accessories therefor<br><br><u>NOTE</u><br><br>In this group, it is desirable to add the indexing codes of group A61L2103/00.	A61L2/00	A61L2/00		1598
A61L2/02	8	using physical processes	A61L2/02	A61L2/02		1785
A61L2/022	9	Filtration	A61L2/022	A61L2/022		646
A61L2/025	9	Ultrasonic waves	A61L2/025	A61L2/025		829
A61L2/03	9	Electric current	A61L2/03	A61L2/03		414
A61L2/035	10	Electrolysis	A61L2/035	A61L2/035		534
A61L2/04	9	Heat (radiation A61L2/08)	A61L2/04	A61L2/04		5616
A61L2/06	10	Hot gas	A61L2/06	A61L2/06		1958
A61L2/07	11	Steam	A61L2/07	A61L2/07		6180
A61L2/08	9	Radiation	A61L2/08	A61L2/08		3364
A61L2/081	10	Gamma radiation	A61L2/081	A61L2/081		672
A61L2/082	10	X-rays	A61L2/082	A61L2/082		250
A61L2/084	10	Visible light	A61L2/084	A61L2/084		680
A61L2/085	10	Infrared radiation	A61L2/085	A61L2/085		1043
A61L2/087	10	Particle radiation, e.g. electron-beam, alpha or beta radiation	A61L2/087	A61L2/087		820
A61L2/088	10	using photocatalysts or photosensitisers	A61L2/088	A61L2/088		914
A61L2/10	10	Ultraviolet [UV] radiation<br><br><u>WARNING</u><br>Group A61L2/10 is impacted by reclassification into groups A61L2/101, A61L2/102, A61L2/104 and A61L2/108. <br>All groups listed in this Warning should be considered in order to perform a complete search.	A61L2/10	A61L2/10		28951
A61L2/101	11	Ultraviolet A [UVA]<br><br><u>WARNING</u><br>Group A61L2/101 is incomplete pending reclassification of documents from group A61L2/10. <br>Groups A61L2/10 and A61L2/101 should be considered in order to perform a complete search.	A61L2/101	A61L2/101		25
A61L2/102	11	Ultraviolet B [UVB]<br><br><u>WARNING</u><br>Group A61L2/102 is incomplete pending reclassification of documents from group A61L2/10. <br>Groups A61L2/10 and A61L2/102 should be considered in order to perform a complete search.	A61L2/102	A61L2/102		12
A61L2/104	11	Ultraviolet C [UVC]<br><br><u>WARNING</u><br>Group A61L2/104 is incomplete pending reclassification of documents from group A61L2/10. <br>Groups A61L2/10 and A61L2/104 should be considered in order to perform a complete search.	A61L2/104	A61L2/104		17
A61L2/108	11	Multiple UV ranges in combination<br><br><u>WARNING</u><br>Group A61L2/108 is incomplete pending reclassification of documents from group A61L2/10. <br>Groups A61L2/10 and A61L2/108 should be considered in order to perform a complete search.	A61L2/108	A61L2/108		12
A61L2/12	10	Microwaves	A61L2/12	A61L2/12		940
A61L2/14	9	Plasma, i.e. ionised gases	A61L2/14	A61L2/14		2848
A61L2/16	8	using chemical substances	A61L2/16	A61L2/16		2264
A61L2/18	9	Liquid substances<br><br><u>WARNING</u><br>Group A61L2/18 is impacted by reclassification into groups A61L2/183 and A61L2/186. <br>Groups A61L2/18, A61L2/183 and A61L2/186 should be considered in order to perform a complete search.	A61L2/18	A61L2/18		19323
A61L2/183	10	Ozone dissolved in a liquid<br><br><u>WARNING</u><br>Group A61L2/183 is incomplete pending reclassification of documents from group A61L2/18. <br>Groups A61L2/18 and A61L2/183 should be considered in order to perform a complete search.	A61L2/183	A61L2/183		923
A61L2/186	10	Peroxide solutions<br><br><u>WARNING</u><br>Group A61L2/186 is incomplete pending reclassification of documents from group A61L2/18. <br>Groups A61L2/18 and A61L2/186 should be considered in order to perform a complete search.	A61L2/186	A61L2/186		1337
A61L2/20	9	Gaseous substances, e.g. vapours<br><br><u>WARNING</u><br>Group A61L2/20 is impacted by reclassification into groups A61L2/202, A61L2/204, A61L2/206 and A61L2/208. <br>All groups listed in this Warning should be considered in order to perform a complete search.	A61L2/20	A61L2/20		3590
A61L2/202	10	Ozone<br><br><u>WARNING</u><br>Group A61L2/202 is incomplete pending reclassification of documents from group A61L2/20. <br>Groups A61L2/20 and A61L2/202 should be considered in order to perform a complete search.	A61L2/202	A61L2/202		4149
A61L2/204	10	Formaldehyde<br><br><u>WARNING</u><br>Group A61L2/204 is incomplete pending reclassification of documents from group A61L2/20. <br>Groups A61L2/20 and A61L2/204 should be considered in order to perform a complete search.	A61L2/204	A61L2/204		327
A61L2/206	10	Ethylene oxide<br><br><u>WARNING</u><br>Group A61L2/206 is incomplete pending reclassification of documents from group A61L2/20. <br>Groups A61L2/20 and A61L2/206 should be considered in order to perform a complete search.	A61L2/206	A61L2/206		903
A61L2/208	10	Hydrogen peroxide<br><br><u>WARNING</u><br>Group A61L2/208 is incomplete pending reclassification of documents from group A61L2/20. <br>Groups A61L2/20 and A61L2/208 should be considered in order to perform a complete search.	A61L2/208	A61L2/208		1549
A61L2/22	9	Phase substances, e.g. smokes or aerosols	A61L2/22	A61L2/22		7510
A61L2/23	9	Solid materials, e.g. granules, powders, blocks or tablets	A61L2/23	A61L2/23		732
A61L2/232	10	layered or coated	A61L2/232	A61L2/232		856
A61L2/235	10	cellular, porous or foamed	A61L2/235	A61L2/235		231
A61L2/238	10	Metals or alloys, e.g. oligodynamic metals	A61L2/238	A61L2/238		961
A61L2/24	8	Apparatus using programmed or automatic operation	A61L2/24	A61L2/24		13008
A61L2/26	8	Accessories	A61L2/26	A61L2/26		22501
A61L2/28	9	Devices for testing the effectiveness or completeness of sterilisation or disinfection, e.g. indicators which change colour	A61L2/28	A61L2/28		1905
A61L9/00	7	Disinfection, sterilisation or deodorisation of air (body deodorants A61Q15/00; purifying air by respirators A62B, A62D9/00; separating dispersed particles from gases or vapours B01D45/00&#160;-&#160;B01D51/00, B03C3/00; chemical or biological purification of waste gases B01D53/34; production of ozone C01B13/10; air-conditioning systems incorporating sterilisation F24F3/16, F24F8/20)	A61L9/00	A61L9/00		2456
A61L9/01	8	Deodorant compositions {(compositions released by contact with a liquid A61L9/05)}	A61L9/01	A61L9/01		4823
A61L9/012	9	characterised by being in a special form, e.g. gels, emulsions {(A61L9/048 takes precedence)}	A61L9/012	A61L9/012		1786
A61L9/013	9	containing animal or plant extracts, or vegetable material	A61L9/013	A61L9/013		3723
A61L9/014	9	containing sorbent material, e.g. activated carbon	A61L9/014	A61L9/014		2864
A61L9/015	8	using gaseous or vaporous substances, e.g. ozone (A61L9/20 takes precedence {; evaporation in general B01B1/005})	A61L9/015	A61L9/015		2483
A61L9/02	9	using substances evaporated in the air by heating or combustion	A61L9/02	A61L9/02		634
A61L9/03	10	Apparatus therefor	A61L9/03	A61L9/03		2569
A61L9/032	11	{comprising a fan}	A61L9/03	A61L9/03		463
A61L9/035	11	{emanating multiple odours}	A61L9/03	A61L9/03		373
A61L9/037	11	{comprising a wick}	A61L9/03	A61L9/03		684
A61L9/04	9	using substances evaporated in the air without heating	A61L9/04	A61L9/04		1428
A61L9/042	10	{with the help of a macromolecular compound as a carrier or diluent (A61L9/048 takes precedence)}	A61L9/04	A61L9/04		993
A61L9/044	10	{with the help of an organic compound other than a macromolecular compound}	A61L9/04	A61L9/04		211
A61L9/046	10	{with the help of a non-organic compound}	A61L9/04	A61L9/04		381
A61L9/048	10	{air treating gels}	A61L9/04	A61L9/04		514
A61L9/05	10	specially adapted to be released by contact with a liquid, e.g. for toilets	A61L9/05	A61L9/05		375
A61L9/12	10	Apparatus, e.g. holders, therefor	A61L9/12	A61L9/12		5824
A61L9/122	11	{comprising a fan}	A61L9/12	A61L9/12		2243
A61L9/125	11	{emanating multiple odours}	A61L9/12	A61L9/12		774
A61L9/127	11	{comprising a wick}	A61L9/12	A61L9/12		1167
A61L9/14	8	using sprayed or atomised substances {including air-liquid contact processes}	A61L9/14	A61L9/14		5804
A61L9/145	9	{air-liquid contact processes, e.g. scrubbing}	A61L9/14	A61L9/14		1625
A61L9/16	8	using physical phenomena	A61L9/16	A61L9/16		2908
A61L9/18	9	Radiation (A61L9/22 takes precedence)	A61L9/18	A61L9/18		1330
A61L9/20	10	Ultraviolet radiation	A61L9/20	A61L9/20		8297
A61L9/205	11	{using a photocatalyst or photosensitiser}	A61L9/20	A61L9/20		3074
A61L9/22	9	Ionisation	A61L9/22	A61L9/22		5777
A61L11/00	7	Methods specially adapted for refuse {(disintegrating medical waste B02C19/0075; disposal of medical waste B09B3/00)}	A61L11/00	A61L11/00		3071
A61L12/00	7	Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor	A61L12/00	A61L12/00		65
A61L12/02	8	using physical phenomena, e.g. electricity, ultrasound or ultrafiltration	A61L12/02	A61L12/02		44
A61L12/023	9	{Electrolysis}	A61L12/02	A61L12/02		49
A61L12/026	9	{Ultrasounds}	A61L12/02	A61L12/02		45
A61L12/04	9	Heat (A61L12/06 takes precedence)	A61L12/04	A61L12/04		137
A61L12/06	9	Radiation, e.g. ultraviolet or microwaves	A61L12/06	A61L12/06		33
A61L12/063	10	{Ultraviolet radiation}	A61L12/06	A61L12/06		95
A61L12/066	10	{Microwaves}	A61L12/06	A61L12/06		14
A61L12/08	8	using chemical substances	A61L12/08	A61L12/08		221
A61L12/082	9	{in combination with specific enzymes}	A61L12/08	A61L12/08		64
A61L12/084	9	{in a gaseous state}	A61L12/08	A61L12/08		13
A61L12/086	9	{Container, accessories or devices therefor}	A61L12/08	A61L12/08		219
A61L12/088	9	{Heavy metals}	A61L12/08	A61L12/08		48
A61L12/10	9	Halogens or compounds thereof	A61L12/10	A61L12/10		48
A61L12/102	10	{Chlorine dioxide (ClO2)}	A61L12/10	A61L12/10		53
A61L12/105	10	{Iodine, iodides or iodophores}	A61L12/10	A61L12/10		20
A61L12/107	10	{Hypohalites; Active halogens}	A61L12/10	A61L12/10		35
A61L12/12	9	Non-macromolecular oxygen-containing compounds, e.g. hydrogen peroxide or ozone (A61L12/10 takes precedence)	A61L12/12	A61L12/12		51
A61L12/122	10	{Ozone}	A61L12/12	A61L12/12		28
A61L12/124	10	{Hydrogen peroxide; Peroxy compounds}	A61L12/12	A61L12/12		169
A61L12/126	11	{neutralised with catalase or peroxidase}	A61L12/12	A61L12/12		68
A61L12/128	11	{neutralised with catalysts}	A61L12/12	A61L12/12		85
A61L12/14	9	Organic compounds not covered by groups A61L12/10 or A61L12/12	A61L12/14	A61L12/14		218
A61L12/141	10	{Biguanides, e.g. chlorhexidine}	A61L12/14	A61L12/14		105
A61L12/142	11	{Polymeric biguanides}	A61L12/14	A61L12/14		134
A61L12/143	10	{Quaternary ammonium compounds}	A61L12/14	A61L12/14		91
A61L12/145	11	{Polymeric quaternary ammonium compounds}	A61L12/14	A61L12/14		109
A61L12/146	10	{Aldehydes}	A61L12/14	A61L12/14		4
A61L12/147	10	{Alcohols or derivatives thereof (aldehydes A61L12/146)}	A61L12/14	A61L12/14		35
A61L12/148	10	{Mercury containing compounds, e.g. thimerosal}	A61L12/14	A61L12/14		20
A61L15/00	7	Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads (for liquid bandages A61L26/00; radioactive dressings {A61N5/1029})<br><br><u>NOTE</u><br><br> In groups A61L15/08 -  A61L15/12, the last place priority rule is applied, i.e. at each hierarchical level, in the absence of an indication to the contrary, classification is made in the last appropriate place.<br> When classifying in groups A61L15/08&#160;-&#160;A61L15/12, classification is also made in group A61L15/14 if the use of materials characterised by their function or physical properties is of interest. <br>In groups A61L15/18 - A61L15/40, the last place priority rule is applied, i.e. at each hierarchical level, in the absence of an indication to the contrary, classification is made in the last appropriate place. This Note corresponds to IPC Note (1) relating to A61L15/18 - A61L15/40.<br>When classifying in groups A61L15/18 - A61L15/40, classification is also made in group A61L15/42 if the use of materials characterised by their function or physical properties is of interest.	A61L15/00	A61L15/00		256
A61L15/07	8	Stiffening bandages	A61L15/07	A61L15/07		257
A61L15/08	9	containing inorganic materials, e.g. plaster of Paris	A61L15/08	A61L15/08		232
A61L15/10	9	containing organic materials	A61L15/10	A61L15/10		82
A61L15/12	9	containing macromolecular materials<br><br><u>NOTE</u><br><br> In group A61L15/12 and subgroups, the use of specific polymers is indicated using the relevant combination set symbol, adding, after the A61L15/12 symbol, the correspondent symbol of the polymer composition in subclass C08L, e.g. stiffening bandage based on polyurethane A61L15/12, C08L75/04	A61L15/12	A61L15/12		469
A61L15/125	10	{Mixtures of macromolecular compounds}	A61L15/12	A61L15/12		102
A61L15/14	9	Use of materials characterised by their function or physical properties	A61L15/14	A61L15/14		217
A61L15/16	8	Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons	A61L15/16	A61L15/16		230
A61L15/18	9	containing inorganic materials	A61L15/18	A61L15/18		3401
A61L15/20	9	containing organic materials	A61L15/20	A61L15/20		2459
A61L15/22	9	containing macromolecular materials<br><br><u>NOTE</u><br><br> In groups A61L15/22&#160;-&#160;A61L15/30, the use of specific polymers is indicated using the relevant combination set symbol, adding, after the symbol in A61L, the correspondent symbol of the polymer in subclass C08L, e.g. absorbent pad containing starch A61L15/22, C08L3/02	A61L15/22	A61L15/22		691
A61L15/225	10	{Mixtures of macromolecular compounds}	A61L15/22	A61L15/22		1376
A61L15/24	10	Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof {(A61L15/225 takes precedence)}	A61L15/24	A61L15/24		2869
A61L15/26	10	Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof {(A61L15/225 takes precedence)}	A61L15/26	A61L15/26		3357
A61L15/28	10	Polysaccharides or their derivatives {(A61L15/225 takes precedence)}	A61L15/28	A61L15/28		4733
A61L15/30	10	Rubbers or their derivatives {(A61L15/225 takes precedence)}	A61L15/30	A61L15/30		83
A61L15/32	10	Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin {(A61L15/225 takes precedence)}	A61L15/32	A61L15/32		1614
A61L15/325	11	{Collagen}	A61L15/32	A61L15/32		1065
A61L15/34	10	Oils, fats, waxes or natural resins {(A61L15/225 takes precedence)}	A61L15/34	A61L15/34		473
A61L15/36	9	containing microorganisms	A61L15/36	A61L15/36		175
A61L15/38	9	containing enzymes	A61L15/38	A61L15/38		279
A61L15/40	9	containing ingredients of undetermined constitution or reaction products thereof {, e.g. plant or animal extracts}	A61L15/40	A61L15/40		2649
A61L15/42	9	Use of materials characterised by their function or physical properties (liquid bandages A61L26/00)	A61L15/42	A61L15/42		3477
A61L15/425	10	{Porous materials, e.g. foams or sponges}	A61L15/42	A61L15/42		2590
A61L15/44	10	Medicaments	A61L15/44	A61L15/44		5693
A61L15/46	10	Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria	A61L15/46	A61L15/46		5467
A61L15/48	10	Surfactants	A61L15/48	A61L15/48		369
A61L15/50	10	Lubricants; Anti-adhesive agents	A61L15/50	A61L15/50		177
A61L15/52	10	Water-repellants	A61L15/52	A61L15/52		129
A61L15/54	10	Radio-opaque materials	A61L15/54	A61L15/54		64
A61L15/56	10	Wetness-indicators or colourants	A61L15/56	A61L15/56		352
A61L15/58	10	Adhesives	A61L15/58	A61L15/58		1786
A61L15/585	11	{Mixtures of macromolecular compounds}	A61L15/58	A61L15/58		521
A61L15/60	10	Liquid-swellable gel-forming materials, e.g. super-absorbents	A61L15/60	A61L15/60		3582
A61L15/62	10	{Compostable,} hydrosoluble or hydrodegradable materials	A61L15/62	A61L15/62		823
A61L15/64	10	specially adapted to be resorbable inside the body	A61L15/64	A61L15/64		608
A61L17/00	7	Materials for surgical sutures or for ligaturing blood vessels (surgical adhesives A61L24/00; surgical instruments, devices or methods for suturing or ligaturing A61B17/04, A61B17/12; supports or packages for suture materials A61B17/04); {Materials for prostheses or catheters (bone cements or surgical adhesives for soft body tissues A61L24/00; shape or structure of prostheses A61F2/00; shape or structure of catheters A61M5/00)}<br><br><u>NOTE</u><br><br> In groups A61L17/04 -  A61L17/145, the last place priority rule is applied, i.e. at each hierarchical level, in the absence of an indication to the contrary, classification is made in the last appropriate place.<br><br> When classifying in group A61L17/00, classification is also made in A61L33/00 if the materials used are antithrombogenic. 	A61L17/00	A61L17/00		234
A61L17/005	8	{containing a biologically active substance, e.g. a medicament or a biocide}	A61L17/00	A61L17/00		761
A61L17/04	8	Non-resorbable materials	A61L17/04	A61L17/04		275
A61L17/06	8	At least partially resorbable materials	A61L17/06	A61L17/06		249
A61L17/08	9	of animal origin, e.g. catgut, collagen	A61L17/08	A61L17/08		467
A61L17/10	9	containing macromolecular materials	A61L17/10	A61L17/10		695
A61L17/105	10	{Polyesters not covered by A61L17/12}	A61L17/10	A61L17/10		318
A61L17/12	10	Homopolymers or copolymers of glycolic acid or lactic acid	A61L17/12	A61L17/12		562
A61L17/14	8	Post-treatment to improve physical properties	A61L17/14	A61L17/14		275
A61L17/145	9	{Coating}	A61L17/14	A61L17/14		635
A61L24/00	7	Surgical adhesives or cements; Adhesives for colostomy devices<br><br><u>NOTE</u><br><br>  In groups A61L24/00&#160;-&#160;A61L24/12, the use of specific polymers is indicated using the relevant combination set symbol, adding, after the symbol in A61L, the correspondent symbol of the polymer in subclass C08L, e.g. surgical adhesives based on polymethylmethacrylate: A61L24/06, C08L33/12<br> In groups A61L24/00 -  A61L24/12, the last place priority rule is applied, i.e. at each hierarchical level, in the absence of an indication to the contrary, classification is made in the last appropriate place.<br> When classifying in group A61L24/00, classification is also made in A61L33/00 if the materials used are antithrombogenic. 	A61L24/00	A61L24/00		313
A61L24/0005	8	{Ingredients of undetermined constitution or reaction products thereof}	A61L24/00	A61L24/00		555
A61L24/001	8	{Use of materials characterised by their function or physical properties}	A61L24/00	A61L24/00		1990
A61L24/0015	9	{Medicaments; Biocides}	A61L24/00	A61L24/00		2484
A61L24/0021	9	{Plasticisers}	A61L24/00	A61L24/00		64
A61L24/0026	9	{Sprayable compositions}	A61L24/00	A61L24/00		82
A61L24/0031	9	{Hydrogels or hydrocolloids}	A61L24/00	A61L24/00		1305
A61L24/0036	9	{Porous materials, e.g. foams or sponges}	A61L24/00	A61L24/00		1106
A61L24/0042	9	{Materials resorbable by the body}	A61L24/00	A61L24/00		1319
A61L24/0047	8	{Composite materials, i.e. containing one material dispersed in a matrix of the same or different material}	A61L24/00	A61L24/00		25
A61L24/0052	9	{with an inorganic matrix}	A61L24/00	A61L24/00		10
A61L24/0057	10	{Carbon}	A61L24/00	A61L24/00		3
A61L24/0063	10	{Phosphorus containing materials, e.g. apatite}	A61L24/00	A61L24/00		112
A61L24/0068	10	{Inorganic materials not covered by groups A61L24/0057 or A61L24/0063}	A61L24/00	A61L24/00		50
A61L24/0073	9	{with a macromolecular matrix}	A61L24/00	A61L24/00		105
A61L24/0078	10	{containing fillers of carbon}	A61L24/00	A61L24/00		12
A61L24/0084	10	{containing fillers of phosphorus-containing inorganic compounds, e.g. apatite}	A61L24/00	A61L24/00		230
A61L24/0089	10	{containing inorganic fillers not covered by groups A61L24/0078 or A61L24/0084}	A61L24/00	A61L24/00		250
A61L24/0094	10	{containing macromolecular fillers}	A61L24/00	A61L24/00		223
A61L24/02	8	containing inorganic materials	A61L24/02	A61L24/02		1307
A61L24/04	8	containing macromolecular materials	A61L24/04	A61L24/04		264
A61L24/043	9	{Mixtures of macromolecular materials}	A61L24/04	A61L24/04		1029
A61L24/046	9	{obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds (A61L24/043 takes precedence)}	A61L24/04	A61L24/04		1404
A61L24/06	9	obtained by reactions only involving carbon-to-carbon unsaturated bonds {(A61L24/043, A61L24/046 take precedence)}	A61L24/06	A61L24/06		1522
A61L24/08	9	Polysaccharides {(A61L24/043 takes precedence)}	A61L24/08	A61L24/08		1774
A61L24/10	9	Polypeptides; Proteins {(A61L24/043 takes precedence)}	A61L24/10	A61L24/10		209
A61L24/102	10	{Collagen}	A61L24/10	A61L24/10		436
A61L24/104	10	{Gelatin}	A61L24/10	A61L24/10		532
A61L24/106	10	{Fibrin; Fibrinogen}	A61L24/10	A61L24/10		464
A61L24/108	10	{Specific proteins or polypeptides not covered by groups A61L24/102&#160;-&#160;A61L24/106}	A61L24/10	A61L24/10		585
A61L24/12	9	Ionomer cements, e.g. glass-ionomer cements {(A61L24/043 takes precedence)}	A61L24/12	A61L24/12		35
A61L26/00	7	Chemical aspects of, or use of materials for, {wound dressings or} bandages {in liquid, gel or powder form}<br><br><u>NOTE</u><br><br> When classifying in group A61L26/00, classification is also made in A61L33/00 if the materials used are antithrombogenic. <br> In groups A61L26/00&#160;-&#160;A61L26/0095, the use of specific polymers is indicated using the relevant combination set symbol, adding, after the symbol in A61L, the correspondent symbol of the polymer in subclass C08L, e.g. liquid bandages on alginates: A61L26/0023, C08L5/04	A61L26/00	A61L26/00		300
A61L26/0004	8	{containing inorganic materials}	A61L26/00	A61L26/00		1348
A61L26/0009	8	{containing macromolecular materials}	A61L26/00	A61L26/00		92
A61L26/0014	9	{obtained by reactions only involving carbon-to-carbon unsaturated bonds}	A61L26/00	A61L26/00		1312
A61L26/0019	9	{obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds}	A61L26/00	A61L26/00		1282
A61L26/0023	9	{Polysaccharides}	A61L26/00	A61L26/00		2704
A61L26/0028	9	{Polypeptides; Proteins; Degradation products thereof}	A61L26/00	A61L26/00		132
A61L26/0033	10	{Collagen}	A61L26/00	A61L26/00		541
A61L26/0038	10	{Gelatin}	A61L26/00	A61L26/00		491
A61L26/0042	10	{Fibrin; Fibrinogen}	A61L26/00	A61L26/00		141
A61L26/0047	10	{Specific proteins or polypeptides not covered by groups A61L26/0033&#160;-&#160;A61L26/0042}	A61L26/00	A61L26/00		731
A61L26/0052	9	{Mixtures of macromolecular compounds}	A61L26/00	A61L26/00		708
A61L26/0057	8	{Ingredients of undetermined constitution or reaction products thereof}	A61L26/00	A61L26/00		981
A61L26/0061	8	{Use of materials characterised by their function or physical properties}	A61L26/00	A61L26/00		1328
A61L26/0066	9	{Medicaments; Biocides}	A61L26/00	A61L26/00		3986
A61L26/0071	9	{Plasticisers}	A61L26/00	A61L26/00		69
A61L26/0076	9	{Sprayable compositions}	A61L26/00	A61L26/00		375
A61L26/008	9	{Hydrogels or hydrocolloids}	A61L26/00	A61L26/00		3402
A61L26/0085	9	{Porous materials, e.g. foams or sponges}	A61L26/00	A61L26/00		727
A61L26/009	9	{Materials resorbable by the body}	A61L26/00	A61L26/00		670
A61L26/0095	8	{Composite materials, i.e. containing one material dispersed in a matrix of the same or different material}	A61L26/00	A61L26/00		333
A61L27/00	7	Materials for {grafts or} prostheses or for coating {grafts or} prostheses (dental prostheses A61C13/00; shape or structure of prostheses A61F2/00; use of preparations for artificial teeth A61K6/80; artificial kidneys A61M1/14)<br><br><u>NOTE</u><br><br> In groups A61L27/02 -  A61L27/48, the last place priority rule is applied, i.e. at each hierarchical level, in the absence of an indication to the contrary, classification is made in the last appropriate place.<br> When classifying in groups A61L27/02 -  A61L27/48, classification is also made in groups A61L27/50 - A61L27/60 if the use of materials characterised by their function or physical properties is of interest.<br><br> When classifying in group A61L27/00, classification is also made in A61L33/00 if the materials used are antithrombogenic <br> In group A61L27/00, the use of specific polymers is indicated using the relevant classification symbols of subclass C08L in the second position of the combination set, e.g. prosthesis based on polyvinylchloride A61L27/16, C08L27/06	A61L27/00	A61L27/00		622
A61L27/02	8	Inorganic materials	A61L27/02	A61L27/02		309
A61L27/025	9	{Other specific inorganic materials not covered by A61L27/04&#160;-&#160;A61L27/12}	A61L27/02	A61L27/02		2065
A61L27/04	9	Metals or alloys	A61L27/04	A61L27/04		1041
A61L27/042	10	{Iron or iron alloys}	A61L27/04	A61L27/04		277
A61L27/045	10	{Cobalt or cobalt alloys}	A61L27/04	A61L27/04		271
A61L27/047	10	{Other specific metals or alloys not covered by A61L27/042&#160;-&#160;A61L27/045 or A61L27/06}	A61L27/04	A61L27/04		1860
A61L27/06	10	Titanium or titanium alloys	A61L27/06	A61L27/06		2798
A61L27/08	9	Carbon {; Graphite}	A61L27/08	A61L27/08		673
A61L27/10	9	Ceramics or glasses	A61L27/10	A61L27/10		1869
A61L27/105	10	{containing Al2O3}	A61L27/10	A61L27/10		214
A61L27/12	9	Phosphorus-containing materials, e.g. apatite	A61L27/12	A61L27/12		4149
A61L27/14	8	Macromolecular materials	A61L27/14	A61L27/14		1416
A61L27/16	9	obtained by reactions only involving carbon-to-carbon unsaturated bonds	A61L27/16	A61L27/16		3652
A61L27/165	10	{Rubbers}	A61L27/16	A61L27/16		50
A61L27/18	9	obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds	A61L27/18	A61L27/18		8319
A61L27/20	9	Polysaccharides	A61L27/20	A61L27/20		6028
A61L27/22	9	Polypeptides or derivatives thereof {, e.g. degradation products}	A61L27/22	A61L27/22		690
A61L27/222	10	{Gelatin}	A61L27/22	A61L27/22		1929
A61L27/225	10	{Fibrin; Fibrinogen}	A61L27/22	A61L27/22		620
A61L27/227	10	{Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24}	A61L27/22	A61L27/22		3332
A61L27/24	10	Collagen	A61L27/24	A61L27/24		4180
A61L27/26	9	Mixtures of macromolecular compounds	A61L27/26	A61L27/26		2499
A61L27/28	8	Materials for coating prostheses	A61L27/28	A61L27/28		1011
A61L27/30	9	Inorganic materials	A61L27/30	A61L27/30		564
A61L27/303	10	{Carbon}	A61L27/30	A61L27/30		405
A61L27/306	10	{Other specific inorganic materials not covered by A61L27/303&#160;-&#160;A61L27/32}	A61L27/30	A61L27/30		2246
A61L27/32	10	Phosphorus-containing materials, e.g. apatite	A61L27/32	A61L27/32		1554
A61L27/34	9	Macromolecular materials	A61L27/34	A61L27/34		5304
A61L27/36	8	containing ingredients of undetermined constitution or reaction products thereof {, e.g. transplant tissue, natural bone, extracellular matrix (isolated natural compounds, e.g. collagen A61L27/24)}	A61L27/36	A61L27/36		765
A61L27/3604	9	{characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel}	A61L27/36	A61L27/36		2768
A61L27/3608	10	{Bone, e.g. demineralised bone matrix [DBM], bone powder}	A61L27/36	A61L27/36		1474
A61L27/3612	10	{Cartilage, synovial fluid}	A61L27/36	A61L27/36		402
A61L27/3616	10	{Blood, e.g. platelet-rich plasma}	A61L27/36	A61L27/36		458
A61L27/362	10	{Skin, e.g. dermal papillae}	A61L27/36	A61L27/36		522
A61L27/3625	10	{Vascular tissue, e.g. heart valves}	A61L27/36	A61L27/36		498
A61L27/3629	10	{Intestinal tissue, e.g. small intestinal submucosa}	A61L27/36	A61L27/36		396
A61L27/3633	10	{Extracellular matrix [ECM]}	A61L27/36	A61L27/36		1693
A61L27/3637	9	{characterised by the origin of the biological material other than human or animal, e.g. plant extracts, algae}	A61L27/36	A61L27/36		346
A61L27/3641	9	{characterised by the site of application in the body (materials for artificial blood vessels A61L27/507; materials for use in artificial skin A61L27/60)}	A61L27/36	A61L27/36		563
A61L27/3645	10	{Connective tissue}	A61L27/36	A61L27/36		228
A61L27/365	11	{Bones}	A61L27/36	A61L27/36		1190
A61L27/3654	11	{Cartilage, e.g. meniscus}	A61L27/36	A61L27/36		450
A61L27/3658	12	{Intervertebral discs (mechanical aspects and structures of intervertebral discs A61F2/442)}	A61L27/36	A61L27/36		99
A61L27/3662	11	{Ligaments, tendons}	A61L27/36	A61L27/36		189
A61L27/3666	10	{Epithelial tissues other than skin}	A61L27/36	A61L27/36		67
A61L27/367	10	{Muscle tissue, e.g. sphincter}	A61L27/36	A61L27/36		120
A61L27/3675	10	{Nerve tissue, e.g. brain, spinal cord, nerves, dura mater}	A61L27/36	A61L27/36		252
A61L27/3679	10	{Hollow organs, e.g. bladder, esophagus, urether, uterus, intestine}	A61L27/36	A61L27/36		161
A61L27/3683	9	{subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment}	A61L27/36	A61L27/36		1117
A61L27/3687	10	{characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents}	A61L27/36	A61L27/36		2480
A61L27/3691	10	{characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation}	A61L27/36	A61L27/36		1871
A61L27/3695	10	{characterised by the function or physical properties of the final product, where no specific conditions are defined to achieve this (A61L27/3687, A61L27/3691 take precedence)}	A61L27/36	A61L27/36		224
A61L27/38	9	{containing added animal cells (organs or tissue containing native cells A61L27/36)}	A61L27/38	A61L27/38		1751
A61L27/3804	10	{characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells}	A61L27/38	A61L27/38		1837
A61L27/3808	11	{Endothelial cells}	A61L27/38	A61L27/38		555
A61L27/3813	11	{Epithelial cells, e.g. keratinocytes, urothelial cells}	A61L27/38	A61L27/38		509
A61L27/3817	11	{Cartilage-forming cells, e.g. pre-chondrocytes}	A61L27/38	A61L27/38		610
A61L27/3821	11	{Bone-forming cells, e.g. osteoblasts, osteocytes, osteoprogenitor cells}	A61L27/38	A61L27/38		410
A61L27/3826	11	{Muscle cells, e.g. smooth muscle cells}	A61L27/38	A61L27/38		375
A61L27/383	11	{Nerve cells, e.g. dendritic cells, Schwann cells}	A61L27/38	A61L27/38		314
A61L27/3834	11	{Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells}	A61L27/38	A61L27/38		2656
A61L27/3839	10	{characterised by the site of application in the body (materials for artificial blood vessels A61L27/507; materials for use in artificial skin A61L27/60)}	A61L27/38	A61L27/38		565
A61L27/3843	11	{Connective tissue}	A61L27/38	A61L27/38		191
A61L27/3847	12	{Bones}	A61L27/38	A61L27/38		671
A61L27/3852	12	{Cartilage, e.g. meniscus}	A61L27/38	A61L27/38		593
A61L27/3856	13	{Intervertebral discs (mechanical aspects and structures of intervertebral discs A61F2/442)}	A61L27/38	A61L27/38		105
A61L27/386	12	{Ligaments, tendons}	A61L27/38	A61L27/38		96
A61L27/3865	12	{Dental/periodontal tissues}	A61L27/38	A61L27/38		127
A61L27/3869	11	{Epithelial tissues other than skin}	A61L27/38	A61L27/38		63
A61L27/3873	11	{Muscle tissue, e.g. sphincter}	A61L27/38	A61L27/38		148
A61L27/3878	11	{Nerve tissue, brain, spinal cord, nerves, dura mater}	A61L27/38	A61L27/38		249
A61L27/3882	11	{Hollow organs, e.g. bladder, esophagus, urether, uterus}	A61L27/38	A61L27/38		146
A61L27/3886	10	{comprising two or more cell types}	A61L27/38	A61L27/38		445
A61L27/3891	11	{as distinct cell layers}	A61L27/38	A61L27/38		204
A61L27/3895	10	{using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions}	A61L27/38	A61L27/38		1079
A61L27/40	8	Composite materials, i.e. containing one material dispersed in a matrix of the same or different material	A61L27/40	A61L27/40		461
A61L27/42	9	having an inorganic matrix	A61L27/42	A61L27/42		135
A61L27/422	10	{of carbon}	A61L27/42	A61L27/42		52
A61L27/425	10	{of phosphorus containing material, e.g. apatite}	A61L27/42	A61L27/42		538
A61L27/427	10	{of other specific inorganic materials not covered by A61L27/422 or A61L27/425}	A61L27/42	A61L27/42		353
A61L27/44	9	having a macromolecular matrix	A61L27/44	A61L27/44		805
A61L27/443	10	{with carbon fillers}	A61L27/44	A61L27/44		293
A61L27/446	10	{with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46}	A61L27/44	A61L27/44		1330
A61L27/46	10	with phosphorus-containing inorganic fillers	A61L27/46	A61L27/46		2026
A61L27/48	10	with macromolecular fillers	A61L27/48	A61L27/48		1476
A61L27/50	8	Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}	A61L27/50	A61L27/50		11196
A61L27/502	9	{Plasticizers}	A61L27/50	A61L27/50		107
A61L27/505	9	{Stabilizers}	A61L27/50	A61L27/50		123
A61L27/507	9	{for artificial blood vessels (apparatus for applying cells on a blood vessel prosthesis A61F2/062)}	A61L27/50	A61L27/50		1821
A61L27/52	9	Hydrogels or hydrocolloids	A61L27/52	A61L27/52		6927
A61L27/54	9	Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}	A61L27/54	A61L27/54		14735
A61L27/56	9	Porous materials, {e.g. foams or sponges}	A61L27/56	A61L27/56		9789
A61L27/58	9	Materials at least partially resorbable by the body	A61L27/58	A61L27/58		7486
A61L27/60	9	Materials for use in artificial skin	A61L27/60	A61L27/60		1975
A61L28/00	7	Materials for colostomy devices (adhesives for colostomy devices A61L24/00)<br><br><u>NOTE</u><br><br> When classifying in group A61L28/00, classification is also made in A61L33/00 if the materials used are antithrombogenic. 	A61L28/00	A61L28/00		16
A61L28/0003	8	{containing inorganic materials}	A61L28/00	A61L28/00		17
A61L28/0007	8	{containing macromolecular materials}	A61L28/00	A61L28/00		14
A61L28/0011	9	{obtained by reactions only involving carbon-to-carbon unsaturated bonds}	A61L28/00	A61L28/00		39
A61L28/0015	9	{obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds}	A61L28/00	A61L28/00		32
A61L28/0019	9	{Polysaccharides}	A61L28/00	A61L28/00		30
A61L28/0023	9	{Polypeptides; Proteins; Degradation products thereof}	A61L28/00	A61L28/00		4
A61L28/0026	9	{Mixtures of macromolecular compounds}	A61L28/00	A61L28/00		43
A61L28/003	8	{Ingredients of undetermined constitution or reaction products thereof}	A61L28/00	A61L28/00		9
A61L28/0034	8	{Use of materials characterised by their function or physical properties}	A61L28/00	A61L28/00		37
A61L28/0038	9	{Medicaments; Biocides}	A61L28/00	A61L28/00		26
A61L28/0042	9	{Plasticisers}	A61L28/00	A61L28/00		2
A61L28/0046	9	{Sprayable compositions}	A61L28/00	A61L28/00		1
A61L28/0049	9	{Hydrogels or hydrocolloids}	A61L28/00	A61L28/00		18
A61L28/0053	9	{Porous materials, e.g. foams or sponges}	A61L28/00	A61L28/00		15
A61L28/0057	9	{Materials resorbable by the body}	A61L28/00	A61L28/00		8
A61L28/0061	8	{Materials for coating}	A61L28/00	A61L28/00		5
A61L28/0065	9	{Inorganic materials}	A61L28/00	A61L28/00		5
A61L28/0069	9	{Macromolecular materials}	A61L28/00	A61L28/00		25
A61L28/0073	8	{Composite materials, i.e. containing one material dispersed in a matrix of the same or different material}	A61L28/00	A61L28/00		4
A61L28/0076	9	{with an inorganic matrix}	A61L28/00	A61L28/00		
A61L28/008	9	{with a macromolecular matrix}	A61L28/00	A61L28/00		6
A61L28/0084	10	{containing fillers of carbon}	A61L28/00	A61L28/00		
A61L28/0088	10	{containing fillers of phosphorus-containing inorganic compounds}	A61L28/00	A61L28/00		
A61L28/0092	10	{containing inorganic fillers not covered by groups A61L28/0084 or A61L28/0088}	A61L28/00	A61L28/00		8
A61L28/0096	10	{containing macromolecular fillers}	A61L28/00	A61L28/00		8
A61L29/00	7	Materials for catheters, {medical tubing, cannulae, or endoscopes} or for coating catheters (shape or structure of catheters A61M25/00)<br><br><u>NOTE</u><br><br> In groups A61L29/02 - A61L29/126, the last place priority rule is applied, i.e. at each hierarchical level, in the absence of an indication to the contrary, classification is made in the last appropriate place.<br> When classifying in groups A61L29/02&#160;-&#160;A61L29/126 , classification is also made in groups A61L29/14&#160;-&#160;A61L29/18 if the use of materials characterised by their function or physical properties is of interest. <br> When classifying in group A61L29/00, classification is also made in A61L33/00 if the materials used are antithrombogenic <br> In group A61L29/00, the use of specific polymers is indicated using the relevant classification symbols of subclass C08L in the combination set, e.g. a catheter based on polyvinylchloride A61L29/041, C08L27/06	A61L29/00	A61L29/00		66
A61L29/005	8	{Ingredients of undetermined constitution or reaction products thereof}	A61L29/00	A61L29/00		92
A61L29/02	8	Inorganic materials	A61L29/02	A61L29/02		540
A61L29/04	8	Macromolecular materials	A61L29/04	A61L29/04		303
A61L29/041	9	{obtained by reactions only involving carbon-to-carbon unsaturated bonds}	A61L29/04	A61L29/04		752
A61L29/042	10	{Rubbers}	A61L29/04	A61L29/04		83
A61L29/043	9	{Polysaccharides}	A61L29/04	A61L29/04		147
A61L29/044	9	{Proteins; Polypeptides; Degradation products thereof}	A61L29/04	A61L29/04		20
A61L29/045	10	{Collagen}	A61L29/04	A61L29/04		27
A61L29/046	10	{Gelatin}	A61L29/04	A61L29/04		30
A61L29/047	10	{Fibrin; Fibrinogen}	A61L29/04	A61L29/04		2
A61L29/048	10	{Other specific proteins or polypeptides not covered by A61L29/045&#160;-&#160;A61L29/047}	A61L29/04	A61L29/04		84
A61L29/049	9	{Mixtures of macromolecular compounds}	A61L29/04	A61L29/04		383
A61L29/06	9	obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds	A61L29/06	A61L29/06		1283
A61L29/08	8	Materials for coatings	A61L29/08	A61L29/08		769
A61L29/085	9	{Macromolecular materials}	A61L29/08	A61L29/08		2917
A61L29/10	9	Inorganic materials	A61L29/10	A61L29/10		116
A61L29/103	10	{Carbon}	A61L29/10	A61L29/10		92
A61L29/106	10	{Inorganic materials other than carbon}	A61L29/10	A61L29/10		345
A61L29/12	8	Composite materials, i.e. containing one material dispersed in a matrix of the same or different material	A61L29/12	A61L29/12		90
A61L29/123	9	{having an inorganic matrix}	A61L29/12	A61L29/12		25
A61L29/126	9	{having a macromolecular matrix}	A61L29/12	A61L29/12		309
A61L29/14	8	Materials characterised by their function or physical properties {, e.g. lubricating compositions}	A61L29/14	A61L29/14		1643
A61L29/141	9	{Plasticizers}	A61L29/14	A61L29/14		73
A61L29/143	9	{Stabilizers}	A61L29/14	A61L29/14		46
A61L29/145	9	{Hydrogels or hydrocolloids}	A61L29/14	A61L29/14		331
A61L29/146	9	{Porous materials, e.g. foams or sponges}	A61L29/14	A61L29/14		232
A61L29/148	9	{Materials at least partially resorbable by the body}	A61L29/14	A61L29/14		263
A61L29/16	9	Biologically active materials, e.g. therapeutic substances {(A61L29/048 takes precedence)}	A61L29/16	A61L29/16		3065
A61L29/18	9	Materials at least partially X-ray or laser opaque	A61L29/18	A61L29/18		367
A61L31/00	7	Materials for other surgical articles {, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices (shape or structure of stent-grafts A61F2/07, of stents A61F2/82, of surgical gloves A61B42/00, of surgical drapes A61B46/00, of occluding devices A61B17/12022)}<br><br><u>NOTE</u><br><br> In groups A61L31/02 -  A61L31/129, the last place priority rule is applied, i.e. at each hierarchical level, in the absence of an indication to the contrary, classification is made in the last appropriate place.<br><br> When classifying in groups A61L31/02&#160;-&#160;A61L31/129 , classification is also made in groups A61L31/14&#160;-&#160;A61L31/18 if the use of materials characterised by their function or physical properties is of interest. <br> When classifying in group A61L31/00, classification is also made in A61L33/00 if the materials used are antithrombogenic <br> In group A61L31/00, the use of specific polymers is indicated using the relevant classification symbols of subclass C08L in the second position of the combination set, e.g. surgical clamp based on polyvinylchloride A61L31/048, C08L27/06	A61L31/00	A61L31/00		231
A61L31/005	8	{Ingredients of undetermined constitution or reaction products thereof}	A61L31/00	A61L31/00		955
A61L31/02	8	Inorganic materials	A61L31/02	A61L31/02		233
A61L31/022	9	{Metals or alloys}	A61L31/02	A61L31/02		3413
A61L31/024	9	{Carbon; Graphite}	A61L31/02	A61L31/02		234
A61L31/026	9	{Ceramic or ceramic-like structures, e.g. glasses}	A61L31/02	A61L31/02		279
A61L31/028	9	{Other inorganic materials not covered by A61L31/022&#160;-&#160;A61L31/026}	A61L31/02	A61L31/02		670
A61L31/04	8	Macromolecular materials	A61L31/04	A61L31/04		757
A61L31/041	9	{Mixtures of macromolecular compounds}	A61L31/04	A61L31/04		838
A61L31/042	9	{Polysaccharides}	A61L31/04	A61L31/04		1535
A61L31/043	9	{Proteins; Polypeptides; Degradation products thereof}	A61L31/04	A61L31/04		134
A61L31/044	10	{Collagen}	A61L31/04	A61L31/04		623
A61L31/045	10	{Gelatin}	A61L31/04	A61L31/04		309
A61L31/046	10	{Fibrin; Fibrinogen}	A61L31/04	A61L31/04		156
A61L31/047	10	{Other specific proteins or polypeptides not covered by A61L31/044&#160;-&#160;A61L31/046}	A61L31/04	A61L31/04		606
A61L31/048	9	{obtained by reactions only involving carbon-to-carbon unsaturated bonds (A61L31/041 takes precedence)}	A61L31/04	A61L31/04		1506
A61L31/049	10	{Rubbers}	A61L31/04	A61L31/04		97
A61L31/06	9	obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)}	A61L31/06	A61L31/06		3641
A61L31/08	8	Materials for coatings	A61L31/08	A61L31/08		1191
A61L31/082	9	{Inorganic materials}	A61L31/08	A61L31/08		296
A61L31/084	10	{Carbon; Graphite}	A61L31/08	A61L31/08		226
A61L31/086	10	{Phosphorus-containing materials, e.g. apatite}	A61L31/08	A61L31/08		289
A61L31/088	10	{Other specific inorganic materials not covered by A61L31/084 or A61L31/086}	A61L31/08	A61L31/08		1253
A61L31/10	9	Macromolecular materials	A61L31/10	A61L31/10		5730
A61L31/12	8	Composite materials, i.e. containing one material dispersed in a matrix of the same or different material	A61L31/12	A61L31/12		208
A61L31/121	9	{having an inorganic matrix}	A61L31/12	A61L31/12		25
A61L31/122	10	{of carbon}	A61L31/12	A61L31/12		23
A61L31/123	10	{of phosphorus-containing materials, e.g. apatite}	A61L31/12	A61L31/12		39
A61L31/124	10	{of other specific inorganic materials not covered by A61L31/122 or A61L31/123}	A61L31/12	A61L31/12		108
A61L31/125	9	{having a macromolecular matrix}	A61L31/12	A61L31/12		180
A61L31/126	10	{containing carbon fillers}	A61L31/12	A61L31/12		91
A61L31/127	10	{containing fillers of phosphorus-containing inorganic materials}	A61L31/12	A61L31/12		210
A61L31/128	10	{containing other specific inorganic fillers not covered by A61L31/126 or A61L31/127}	A61L31/12	A61L31/12		389
A61L31/129	10	{containing macromolecular fillers}	A61L31/12	A61L31/12		384
A61L31/14	8	Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}	A61L31/14	A61L31/14		4709
A61L31/141	9	{Plasticizers}	A61L31/14	A61L31/14		108
A61L31/143	9	{Stabilizers}	A61L31/14	A61L31/14		84
A61L31/145	9	{Hydrogels or hydrocolloids}	A61L31/14	A61L31/14		1382
A61L31/146	9	{Porous materials, e.g. foams or sponges}	A61L31/14	A61L31/14		1746
A61L31/148	9	{Materials at least partially resorbable by the body}	A61L31/14	A61L31/14		3932
A61L31/16	9	Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)}	A61L31/16	A61L31/16		7989
A61L31/18	9	Materials at least partially X-ray or laser opaque	A61L31/18	A61L31/18		1042
A61L33/00	7	Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment<br><br><u>NOTE</u><br><br>In groups A61L33/0076 -  A61L33/0094 and A61L33/02 -  A61L33/122, the last place priority rule is applied, i.e. at each hierarchical level, in the absence of an indication to the contrary, classification is made in the last appropriate place. <br> When classifying in groups A61L33/02&#160;-&#160;A61L33/122, classification is also made in group A61L33/0005 if of interest <br> In group A61L33/00, the use of specific polymers is indicated using the relevant classification symbols of subclass C08L in the second position of the combination set, e.g. antithrombogenic treatment with the help of polyvinylchloride A61L33/064, C08L27/06	A61L33/00	A61L33/00		101
A61L33/0005	8	{Use of materials characterised by their function or physical properties}	A61L33/00	A61L33/00		117
A61L33/0011	9	{Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate}	A61L33/00	A61L33/00		529
A61L33/0017	10	{using a surface active agent}	A61L33/00	A61L33/00		79
A61L33/0023	10	{using a quaternized group or a protonated amine group of the substrate}	A61L33/00	A61L33/00		62
A61L33/0029	10	{using an intermediate layer of polymer}	A61L33/00	A61L33/00		226
A61L33/0035	10	{using a polymer with positively charged atoms in the polymeric backbone, e.g. ionenes}	A61L33/00	A61L33/00		18
A61L33/0041	10	{characterised by the choice of an antithrombatic agent other than heparin (heparino&#239;d A61L33/08; polypeptides A61L33/12)}	A61L33/00	A61L33/00		216
A61L33/0047	9	{Enzymes, e.g. urokinase, streptokinase}	A61L33/00	A61L33/00		96
A61L33/0052	9	{Plasticizers}	A61L33/00	A61L33/00		22
A61L33/0058	9	{Stabilizers}	A61L33/00	A61L33/00		3
A61L33/0064	9	{Hydrogels or hydrocolloids}	A61L33/00	A61L33/00		36
A61L33/007	9	{Porous materials, e.g. foams or sponges}	A61L33/00	A61L33/00		19
A61L33/0076	8	{Chemical modification of the substrate}	A61L33/00	A61L33/00		120
A61L33/0082	9	{by reacting with an organic compound other than heparin}	A61L33/00	A61L33/00		129
A61L33/0088	9	{by grafting of a monomer onto the substrate}	A61L33/00	A61L33/00		161
A61L33/0094	8	{Physical treatment, e.g. plasma treatment}	A61L33/00	A61L33/00		111
A61L33/02	8	Use of inorganic materials	A61L33/02	A61L33/02		47
A61L33/022	9	{Metal or alloys}	A61L33/02	A61L33/02		66
A61L33/025	9	{Carbon; Graphite}	A61L33/02	A61L33/02		40
A61L33/027	9	{Other specific inorganic materials not covered by A61L33/022 or A61L33/025}	A61L33/02	A61L33/02		63
A61L33/04	8	Use of organic materials, e.g. acetylsalicylic acid	A61L33/04	A61L33/04		118
A61L33/06	8	Use of macromolecular materials (grafting of a monomer onto the substrate A61L33/0088)	A61L33/06	A61L33/06		132
A61L33/062	9	{Mixtures of macromolecular compounds}	A61L33/06	A61L33/06		88
A61L33/064	9	{obtained by reactions only involving carbon-to-carbon unsaturated bonds (A61L33/062 takes precedence)}	A61L33/06	A61L33/06		201
A61L33/066	10	{Rubbers}	A61L33/06	A61L33/06		10
A61L33/068	9	{obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds (A61L33/062 takes precedence)}	A61L33/06	A61L33/06		286
A61L33/08	9	Polysaccharides	A61L33/08	A61L33/08		307
A61L33/12	9	Polypeptides, proteins or derivatives thereof {, e.g. degradation products thereof}	A61L33/12	A61L33/12		47
A61L33/122	10	{Collagen}	A61L33/12	A61L33/12		16
A61L33/124	10	{Gelatin}	A61L33/12	A61L33/12		9
A61L33/126	10	{Fibrin}	A61L33/12	A61L33/12		12
A61L33/128	10	{Other specific proteins or polypeptides not covered by A61L33/122&#160;-&#160;A61L33/126}	A61L33/12	A61L33/12		108
A61L33/18	8	Use of ingredients of undetermined constitution or reaction products thereof	A61L33/18	A61L33/18		49
A61L2101/00	7	Chemical composition of materials used in disinfecting, sterilising or deodorising	A61L101/00	A61L101/00		111
A61L2101/02	8	Inorganic materials	A61L101/02	A61L101/02		489
A61L2101/06	9	containing halogen	A61L101/06	A61L101/06		349
A61L2101/08	10	Elemental halogen	A61L101/08	A61L101/08		50
A61L2101/12	9	containing silicon	A61L101/12	A61L101/12		48
A61L2101/14	9	containing sulfur	A61L101/14	A61L101/14		31
A61L2101/16	9	containing phosphorus	A61L101/16	A61L101/16		32
A61L2101/18	9	Ammonia	A61L101/18	A61L101/18		10
A61L2101/20	9	Acids	A61L101/20	A61L101/20		63
A61L2101/24	9	containing aluminium	A61L101/24	A61L101/24		44
A61L2101/26	9	containing copper	A61L101/26	A61L101/26		95
A61L2101/28	9	containing iron	A61L101/28	A61L101/28		38
A61L2101/30	9	containing zinc	A61L101/30	A61L101/30		74
A61L2101/32	8	Organic compounds	A61L101/32	A61L101/32		229
A61L2101/34	9	Hydroxy compounds	A61L101/34	A61L101/34		592
A61L2101/36	9	Carboxylic acids or derivatives thereof	A61L101/36	A61L101/36		183
A61L2101/38	9	Ethers	A61L101/38	A61L101/38		36
A61L2101/40	9	containing sulfur	A61L101/40	A61L101/40		31
A61L2101/42	9	Organo-metallic compounds or complexes	A61L101/42	A61L101/42		26
A61L2101/44	9	Heterocyclic compounds	A61L101/44	A61L101/44		158
A61L2101/46	9	Macromolecular compounds	A61L101/46	A61L101/46		135
A61L2101/48	10	obtained by reactions only involving carbon-to-carbon unsaturated bonds	A61L101/48	A61L101/48		54
A61L2101/50	10	Polysaccharides or derivatives thereof	A61L101/50	A61L101/50		68
A61L2103/00	7	Materials or objects being the target of disinfection or sterilisation<br><br><u>WARNING</u><br>Group A61L2103/00 is incomplete pending reclassification of documents from group A61L2103/05. Group A61L2103/00 is also impacted by reclassification into groups A61L2103/10, A61L2103/15 - A61L2103/20, A61L2103/25, A61L2103/30, A61L2103/35, A61L2103/40, A61L2103/45, A61L2103/55, A61L2103/60, A61L2103/65, A61L2103/70, A61L2103/80, A61L2103/85 and A61L2103/90. <br>All groups listed in this Warning should be considered in order to perform a complete search.	A61L103/00	A61L103/00		612
A61L2103/05	8	Living organisms or biological materials<br><br><u>WARNING</u><br>Group A61L2103/05 is impacted by reclassification into groups A61L2103/00, A61L2103/06 - A61L2103/07, A61L2103/09, A61L2103/10, A61L2103/20, A61L2103/35, A61L2103/65 and A61L2103/85. <br>All groups listed in this Warning should be considered in order to perform a complete search.	A61L103/05	A61L103/05		6435
A61L2103/06	9	The human body<br><br><u>WARNING</u><br>Groups A61L2103/06 and A61L2103/07 are incomplete pending reclassification of documents from group A61L2103/05. <br>All groups listed in this Warning should be considered in order to perform a complete search.	A61L103/06	A61L103/06		2
A61L2103/07	10	Hands	A61L103/07	A61L103/07		2
A61L2103/09	9	Blood or products thereof<br><br><u>WARNING</u><br>Group A61L2103/09 is incomplete pending reclassification of documents from group A61L2103/05. <br>Groups A61L2103/05 and A61L2103/09 should be considered in order to perform a complete search.	A61L103/09	A61L103/09		368
A61L2103/10	8	Medicinal preparations other than biologicals<br><br><u>WARNING</u><br>Group A61L2103/10 is incomplete pending reclassification of documents from groups A61L2103/00 and A61L2103/05. <br>Groups A61L2103/00, A61L2103/05 and A61L2103/10 should be considered in order to perform a complete search.	A61L103/10	A61L103/10		2
A61L2103/15	8	Laboratory, medical or dentistry appliances, e.g. catheters or sharps<br><br><u>WARNING</u><br>Group A61L2103/15 is incomplete pending reclassification of documents from group A61L2103/00. <br>Groups A61L2103/00 and A61L2103/15 should be considered in order to perform a complete search.	A61L103/15	A61L103/15		11075
A61L2103/20	9	Containers, e.g. vials or flasks<br><br><u>WARNING</u><br>Group A61L2103/20 is incomplete pending reclassification of documents from groups A61L2103/00, A61L2103/05 and A61L2103/23. <br>All groups listed in this Warning should be considered in order to perform a complete search.	A61L103/20	A61L103/20		4
A61L2103/23	8	{Containers other than laboratory or medical, e.g. bottles or mail}<br><br><u>WARNING</u><br>Group A61L2103/23 is impacted by reclassification into group A61L2103/20. <br>Groups A61L2103/23 and A61L2103/20 should be considered in order to perform a complete search.	A61L103/00	A61L2103/23		2864
A61L2103/25	8	Personal electronic items, e.g. mobile phones<br><br><u>WARNING</u><br>Group A61L2103/25 is incomplete pending reclassification of documents from group A61L2103/00. <br>Groups A61L2103/00 and A61L2103/25 should be considered in order to perform a complete search.	A61L103/25	A61L103/25		2
A61L2103/30	8	Tableware or kitchen utensils<br><br><u>WARNING</u><br>Group A61L2103/30 is incomplete pending reclassification of documents from group A61L2103/00. <br>Groups A61L2103/00 and A61L2103/30 should be considered in order to perform a complete search.	A61L103/30	A61L103/30		1
A61L2103/35	8	Baby products, e.g. pacifiers or feeding bottles<br><br><u>WARNING</u><br>Group A61L2103/35 is incomplete pending reclassification of documents from groups A61L2103/00 and A61L2103/05. <br>Groups A61L2103/00, A61L2103/05 and A61L2103/35 should be considered in order to perform a complete search.	A61L103/35	A61L103/35		
A61L2103/40	8	Furniture, e.g. seats, tables or beds<br><br><u>WARNING</u><br>Group A61L2103/40 is incomplete pending reclassification of documents from group A61L2103/00. <br>Groups A61L2103/00 and A61L2103/40 should be considered in order to perform a complete search.	A61L103/40	A61L103/40		2
A61L2103/45	8	Toiletry or cosmetic articles<br><br><u>WARNING</u><br>Group A61L2103/45 is incomplete pending reclassification of documents from group A61L2103/00. <br>Groups A61L2103/00 and A61L2103/45 should be considered in order to perform a complete search.	A61L103/45	A61L103/45		2
A61L2103/50	8	Textiles, e.g. bedwear or towels	A61L103/50	A61L103/50		3499
A61L2103/55	8	Footwear<br><br><u>WARNING</u><br>Group A61L2103/55 is incomplete pending reclassification of documents from group A61L2103/00. <br>Groups A61L2103/00 and A61L2103/55 should be considered in order to perform a complete search.	A61L103/55	A61L103/55		
A61L2103/60	8	Cards or paper money<br><br><u>WARNING</u><br>Group A61L2103/60 is incomplete pending reclassification of documents from group A61L2103/00. <br>Groups A61L2103/00 and A61L2103/60 should be considered in order to perform a complete search.	A61L103/60	A61L103/60		
A61L2103/65	8	Personal protective equipment, e.g. facial masks<br><br><u>WARNING</u><br>Group A61L2103/65 is incomplete pending reclassification of documents from groups A61L2103/00 and A61L2103/05. <br>Groups A61L2103/00, A61L2103/05 and A61L2103/65 should be considered in order to perform a complete search.	A61L103/65	A61L103/65		2
A61L2103/70	8	Trolleys, e.g. supermarket trolleys<br><br><u>WARNING</u><br>Group A61L2103/70 is incomplete pending reclassification of documents from group A61L2103/00. <br>Groups A61L2103/00 and A61L2103/70 should be considered in order to perform a complete search.	A61L103/70	A61L103/70		
A61L2103/75	8	Room floors or walls<br><br><u>WARNING</u><br>Group A61L2103/75 is impacted by reclassification into groups A61L2103/80, A61L2103/95 and A61L2103/97. <br>All groups listed in this Warning should be considered in order to perform a complete search.	A61L103/75	A61L103/75		3499
A61L2103/80	8	Gates, doors or parts thereof, e.g. handles<br><br><u>WARNING</u><br>Group A61L2103/80 is incomplete pending reclassification of documents from groups A61L2103/00 and A61L2103/75. <br>Groups A61L2103/00, A61L2103/75 and A61L2103/80 should be considered in order to perform a complete search.	A61L103/80	A61L103/80		2
A61L2103/85	8	Animal houses<br><br><u>WARNING</u><br>Group A61L2103/85 is incomplete pending reclassification of documents from groups A61L2103/00 and A61L2103/05. <br>Groups A61L2103/00, A61L2103/05 and A61L2103/85 should be considered in order to perform a complete search.	A61L103/85	A61L103/85		1
A61L2103/90	8	Temporarily isolated areas, e.g. mobile tents<br><br><u>WARNING</u><br>Group A61L2103/90 is incomplete pending reclassification of documents from group A61L2103/00. <br>Groups A61L2103/00 and A61L2103/90 should be considered in order to perform a complete search.	A61L103/90	A61L103/90		2
A61L2103/95	8	Vehicles, e.g. cars or aeroplanes<br><br><u>WARNING</u><br>Groups A61L2103/95 and A61L2103/97 are incomplete pending reclassification of documents from group A61L2103/75. <br>Groups A61L2103/75, A61L2103/95 and A61L2103/97 should be considered in order to perform a complete search.	A61L103/95	A61L103/95		2
A61L2103/97	9	Passenger compartments of vehicles	A61L103/97	A61L103/97		2
A61L2202/00	7	Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects	CPCONLY	A61L2202/00		31
A61L2202/10	8	Apparatus features	CPCONLY	A61L2202/10		161
A61L2202/11	9	Apparatus for generating biocidal substances, e.g. vaporisers, UV lamps	CPCONLY	A61L2202/11		9126
A61L2202/12	9	Apparatus for isolating biocidal substances from the environment	CPCONLY	A61L2202/12		388
A61L2202/121	10	Sealings, e.g. doors, covers, valves, sluices	CPCONLY	A61L2202/121		2190
A61L2202/122	10	Chambers for sterilisation	CPCONLY	A61L2202/122		4053
A61L2202/123	10	Connecting means	CPCONLY	A61L2202/123		630
A61L2202/13	9	Biocide decomposition means, e.g. catalysts, sorbents	CPCONLY	A61L2202/13		747
A61L2202/14	9	Means for controlling sterilisation processes, data processing, presentation and storage means, e.g. sensors, controllers, programs	CPCONLY	A61L2202/14		12533
A61L2202/15	9	Biocide distribution means, e.g. nozzles, pumps, manifolds, fans, baffles, sprayers	CPCONLY	A61L2202/15		7416
A61L2202/16	9	Mobile applications, e.g. portable devices, trailers, devices mounted on vehicles	CPCONLY	A61L2202/16		4090
A61L2202/17	9	Combination with washing or cleaning means	CPCONLY	A61L2202/17		5219
A61L2202/18	9	Aseptic storing means	CPCONLY	A61L2202/18		372
A61L2202/181	10	Flexible packaging means, e.g. permeable membranes, paper	CPCONLY	A61L2202/181		384
A61L2202/182	10	Rigid packaging means	CPCONLY	A61L2202/182		671
A61L2209/00	7	Aspects relating to disinfection, sterilisation or deodorisation of air	CPCONLY	A61L2209/00		23
A61L2209/10	8	Apparatus features	CPCONLY	A61L2209/10		352
A61L2209/11	9	Apparatus for controlling air treatment	CPCONLY	A61L2209/11		2854
A61L2209/111	10	Sensor means, e.g. motion, brightness, scent, contaminant sensors	CPCONLY	A61L2209/111		3212
A61L2209/12	9	Lighting means	CPCONLY	A61L2209/12		2425
A61L2209/13	9	Dispensing or storing means for active compounds	CPCONLY	A61L2209/13		908
A61L2209/131	10	Semi-permeable membranes	CPCONLY	A61L2209/131		267
A61L2209/132	10	Piezo or ultrasonic elements for dispensing	CPCONLY	A61L2209/132		480
A61L2209/133	10	Replaceable cartridges, refills	CPCONLY	A61L2209/133		1510
A61L2209/134	10	Distributing means, e.g. baffles, valves, manifolds, nozzles	CPCONLY	A61L2209/134		2872
A61L2209/135	10	Vaporisers for active components	CPCONLY	A61L2209/135		647
A61L2209/14	9	Filtering means	CPCONLY	A61L2209/14		3622
A61L2209/15	9	Supporting means, e.g. stands, hooks, holes for hanging	CPCONLY	A61L2209/15		1430
A61L2209/16	9	Connections to a HVAC unit	CPCONLY	A61L2209/16		1596
A61L2209/20	8	Method-related aspects	CPCONLY	A61L2209/20		51
A61L2209/21	9	Use of chemical compounds for treating air or the like	CPCONLY	A61L2209/21		2885
A61L2209/211	10	Use of hydrogen peroxide, liquid and vaporous	CPCONLY	A61L2209/211		371
A61L2209/212	10	Use of ozone, e.g. generated by UV radiation or electrical discharge	CPCONLY	A61L2209/212		1584
A61L2209/213	10	Use of electrochemically treated water, e.g. electrolysed water or water treated by electrical discharge	CPCONLY	A61L2209/213		251
A61L2209/22	9	Treatment by sorption, e.g. absorption, adsorption, chemisorption, scrubbing, wet cleaning	CPCONLY	A61L2209/22		1481
A61L2300/00	7	Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices	CPCONLY	A61L2300/00		526
A61L2300/10	8	containing or releasing inorganic materials	CPCONLY	A61L2300/10		524
A61L2300/102	9	Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates	CPCONLY	A61L2300/102		3655
A61L2300/104	10	Silver, e.g. silver sulfadiazine	CPCONLY	A61L2300/104		2482
A61L2300/106	9	Halogens or compounds thereof, e.g. iodine, chlorite	CPCONLY	A61L2300/106		387
A61L2300/108	9	Elemental carbon, e.g. charcoal	CPCONLY	A61L2300/108		415
A61L2300/11	9	Peroxy compounds, peroxides, e.g. hydrogen peroxide	CPCONLY	A61L2300/11		210
A61L2300/112	9	Phosphorus-containing compounds, e.g. phosphates, phosphonates	CPCONLY	A61L2300/112		913
A61L2300/114	9	Nitric oxide, i.e. NO	CPCONLY	A61L2300/114		304
A61L2300/20	8	containing or releasing organic materials	CPCONLY	A61L2300/20		113
A61L2300/202	9	with halogen atoms, e.g. triclosan, povidone-iodine	CPCONLY	A61L2300/202		318
A61L2300/204	9	with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines	CPCONLY	A61L2300/204		1031
A61L2300/206	10	Biguanides, e.g. chlorohexidine	CPCONLY	A61L2300/206		491
A61L2300/208	10	Quaternary ammonium compounds	CPCONLY	A61L2300/208		587
A61L2300/21	9	Acids	CPCONLY	A61L2300/21		752
A61L2300/212	10	Peroxy acids, peracids	CPCONLY	A61L2300/212		17
A61L2300/214	10	Amino acids	CPCONLY	A61L2300/214		363
A61L2300/216	9	with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups	CPCONLY	A61L2300/216		2479
A61L2300/22	9	Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes	CPCONLY	A61L2300/22		267
A61L2300/222	10	Steroids, e.g. corticosteroids	CPCONLY	A61L2300/222		293
A61L2300/224	9	containing metals, e.g. porphyrins, vitamin B12	CPCONLY	A61L2300/224		80
A61L2300/23	9	Carbohydrates	CPCONLY	A61L2300/23		237
A61L2300/232	10	Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides	CPCONLY	A61L2300/232		2279
A61L2300/236	10	Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin	CPCONLY	A61L2300/236		1156
A61L2300/25	9	Peptides having up to 20 amino acids in a defined sequence	CPCONLY	A61L2300/25		422
A61L2300/252	9	Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines	CPCONLY	A61L2300/252		3475
A61L2300/254	10	Enzymes, proenzymes	CPCONLY	A61L2300/254		769
A61L2300/256	10	Antibodies, e.g. immunoglobulins, vaccines	CPCONLY	A61L2300/256		255
A61L2300/258	9	Genetic materials, DNA, RNA, genes, vectors, e.g. plasmids	CPCONLY	A61L2300/258		580
A61L2300/30	9	Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera	CPCONLY	A61L2300/30		2926
A61L2300/40	8	characterised by a specific therapeutic activity or mode of action	CPCONLY	A61L2300/40		541
A61L2300/402	9	Anaestetics, analgesics, e.g. lidocaine	CPCONLY	A61L2300/402		1165
A61L2300/404	9	Biocides, antimicrobial agents, antiseptic agents	CPCONLY	A61L2300/404		11645
A61L2300/406	10	Antibiotics	CPCONLY	A61L2300/406		2150
A61L2300/408	10	Virucides, spermicides	CPCONLY	A61L2300/408		258
A61L2300/41	9	Anti-inflammatory agents, e.g. NSAIDs	CPCONLY	A61L2300/41		3289
A61L2300/412	9	Tissue-regenerating or healing or proliferative agents	CPCONLY	A61L2300/412		7817
A61L2300/414	10	Growth factors	CPCONLY	A61L2300/414		3603
A61L2300/416	9	Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus	CPCONLY	A61L2300/416		2881
A61L2300/418	9	Agents promoting blood coagulation, blood-clotting agents, embolising agents	CPCONLY	A61L2300/418		1911
A61L2300/42	9	Anti-thrombotic agents, anticoagulants, anti-platelet agents	CPCONLY	A61L2300/42		1396
A61L2300/422	9	Anti-atherosclerotic agents	CPCONLY	A61L2300/422		103
A61L2300/424	9	Anti-adhesion agents	CPCONLY	A61L2300/424		169
A61L2300/426	9	Immunomodulating agents, i.e. cytokines, interleukins, interferons	CPCONLY	A61L2300/426		562
A61L2300/428	9	Vitamins, e.g. tocopherol, riboflavin	CPCONLY	A61L2300/428		406
A61L2300/43	9	Hormones, e.g. dexamethasone	CPCONLY	A61L2300/43		573
A61L2300/432	9	Inhibitors, antagonists (A61L2300/402&#160;-&#160;A61L2300/43 take precedence)	CPCONLY	A61L2300/432		224
A61L2300/434	10	of enzymes	CPCONLY	A61L2300/434		322
A61L2300/436	10	of receptors	CPCONLY	A61L2300/436		104
A61L2300/438	9	Antigens	CPCONLY	A61L2300/438		26
A61L2300/44	9	Radioisotopes, radionuclides	CPCONLY	A61L2300/44		224
A61L2300/442	9	Colorants, dyes	CPCONLY	A61L2300/442		305
A61L2300/45	9	Mixtures of two or more drugs, e.g. synergistic mixtures	CPCONLY	A61L2300/45		1678
A61L2300/452	9	Lubricants	CPCONLY	A61L2300/452		196
A61L2300/60	8	characterised by a special physical form	CPCONLY	A61L2300/60		153
A61L2300/602	9	Type of release, e.g. controlled, sustained, slow	CPCONLY	A61L2300/602		3719
A61L2300/604	10	Biodegradation	CPCONLY	A61L2300/604		1533
A61L2300/606	9	Coatings	CPCONLY	A61L2300/606		3254
A61L2300/608	10	having two or more layers	CPCONLY	A61L2300/608		772
A61L2300/61	11	containing two or more active agents in different layers	CPCONLY	A61L2300/61		233
A61L2300/62	9	Encapsulated active agents, e.g. emulsified droplets	CPCONLY	A61L2300/62		438
A61L2300/622	10	Microcapsules	CPCONLY	A61L2300/622		960
A61L2300/624	10	Nanocapsules	CPCONLY	A61L2300/624		549
A61L2300/626	10	Liposomes, micelles, vesicles	CPCONLY	A61L2300/626		228
A61L2300/63	9	Crystals	CPCONLY	A61L2300/63		137
A61L2300/64	9	Animal cells	CPCONLY	A61L2300/64		746
A61L2300/80	8	characterised by a special chemical form	CPCONLY	A61L2300/80		122
A61L2300/802	9	Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants	CPCONLY	A61L2300/802		849
A61L2400/00	7	Materials characterised by their function or physical properties	CPCONLY	A61L2400/00		77
A61L2400/02	8	Treatment of implants to prevent calcification or mineralisation in vivo	CPCONLY	A61L2400/02		205
A61L2400/04	8	Materials for stopping bleeding	CPCONLY	A61L2400/04		3705
A61L2400/06	8	Flowable or injectable implant compositions	CPCONLY	A61L2400/06		4855
A61L2400/08	8	Methods for forming porous structures using a negative form which is filled and then removed by pyrolysis or dissolution	CPCONLY	A61L2400/08		205
A61L2400/10	8	Materials for lubricating medical devices	CPCONLY	A61L2400/10		776
A61L2400/12	8	Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces	CPCONLY	A61L2400/12		5255
A61L2400/14	8	Adhesives for ostomy devices	CPCONLY	A61L2400/14		159
A61L2400/16	8	Materials with shape-memory or superelastic properties	CPCONLY	A61L2400/16		970
A61L2400/18	8	Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment	CPCONLY	A61L2400/18		2834
A61L2420/00	7	Materials or methods for coatings medical devices	CPCONLY	A61L2420/00		160
A61L2420/02	8	Methods for coating medical devices	CPCONLY	A61L2420/02		3220
A61L2420/04	8	Coatings containing a composite material such as inorganic/organic, i.e. material comprising different phases	CPCONLY	A61L2420/04		711
A61L2420/06	8	Coatings containing a mixture of two or more compounds	CPCONLY	A61L2420/06		1432
A61L2420/08	8	Coatings comprising two or more layers	CPCONLY	A61L2420/08		1682
A61L2430/00	7	Materials or treatment for tissue regeneration	CPCONLY	A61L2430/00		297
A61L2430/02	8	for reconstruction of bones; weight-bearing implants	CPCONLY	A61L2430/02		10054
A61L2430/04	8	for mammary reconstruction	CPCONLY	A61L2430/04		386
A61L2430/06	8	for cartilage reconstruction, e.g. meniscus	CPCONLY	A61L2430/06		2037
A61L2430/10	8	for reconstruction of tendons or ligaments	CPCONLY	A61L2430/10		739
A61L2430/12	8	for dental implants or prostheses	CPCONLY	A61L2430/12		1782
A61L2430/14	8	for ear reconstruction or ear implants, e.g. implantable hearing aids	CPCONLY	A61L2430/14		201
A61L2430/16	8	for reconstruction of eye parts, e.g. intraocular lens, cornea	CPCONLY	A61L2430/16		1717
A61L2430/18	8	for hair reconstruction	CPCONLY	A61L2430/18		95
A61L2430/20	8	for reconstruction of the heart, e.g. heart valves	CPCONLY	A61L2430/20		1156
A61L2430/22	8	for reconstruction of hollow organs, e.g. bladder, esophagus, urether, uterus	CPCONLY	A61L2430/22		596
A61L2430/24	8	for joint reconstruction	CPCONLY	A61L2430/24		1118
A61L2430/26	8	for kidney reconstruction	CPCONLY	A61L2430/26		86
A61L2430/28	8	for liver reconstruction	CPCONLY	A61L2430/28		183
A61L2430/30	8	for muscle reconstruction	CPCONLY	A61L2430/30		311
A61L2430/32	8	for nerve reconstruction	CPCONLY	A61L2430/32		1406
A61L2430/34	8	for soft tissue reconstruction	CPCONLY	A61L2430/34		2197
A61L2430/36	8	for embolization or occlusion, e.g. vaso-occlusive compositions or devices	CPCONLY	A61L2430/36		770
A61L2430/38	8	for reconstruction of the spine, vertebrae or intervertebral discs	CPCONLY	A61L2430/38		972
A61L2430/40	8	Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking	CPCONLY	A61L2430/40		2065
